MCK · 10-Q · 2026Q2 · Full report

Gross Margin Drivers

MCKESSON CORP · 2026-08-05 · Importance 20 · Surprise 40

Gross profit increased to $3.685 billion for the three months ended June 30, 2026 from $3.279 billion in the prior-year period. Gross margin expanded to 3.50% from 3.35%, an improvement of 15 basis points. The increase was driven primarily by higher North American Pharmaceutical volumes from retail national account and institutional healthcare customers. Oncology & Multispecialty also contributed through specialty pharmaceutical growth and the addition of providers in practice management.

Key facts

• Three months ended June 30, 2026 Gross profit: $3,685 million source
• Gross profit for the three months ended June 30, 2026: $3,685 million; for the three months ended June 30, 2025: $3,279 million. source
• Gross profit margin for the three months ended June 30, 2026: 3.50%; for the three months ended June 30, 2025: 3.35%. source